9/3/24 17:33 | 9/3/24 | NRIX | Health | Drug | Pharmaceutical Preparations | Ring Christine | CA | O | GC | S.d | -226 | 24.94 | 0 | -9 | -27 | 25 | D | | | | | | | | | | | | | | |
9/3/24 17:33 | 9/3/24 | NRIX | Health | Drug | Pharmaceutical Preparations | Ring Christine | CA | O | GC | M.d | 42 | 4.66 | 0 | 9 | 58 | 25 | D | | | | | | | | | | | | | | |
8/26/24 18:23 | 8/26/24 | NRIX | Health | Drug | Pharmaceutical Preparations | Ring Christine | CA | O | GC | S.d | -247 | 25.01 | 0 | -10 | -29 | 25 | D | | | | | | | | | | | | | | |
8/26/24 18:23 | 8/26/24 | NRIX | Health | Drug | Pharmaceutical Preparations | Ring Christine | CA | O | GC | M.d | 60 | 6.08 | 0 | 10 | 67 | 25 | D | | | | | | | | | | | | | | |
8/26/24 17:41 | 8/26/24 | NRIX | Health | Drug | Pharmaceutical Preparations | Van Houte Hans | CA | O | CFO | S | -504 | 25.22 | 0 | -20 | -39 | 31 | D | | | | | | | | | | | | | | |
8/1/24 19:06 | 8/1/24 | NRIX | Health | Drug | Pharmaceutical Preparations | Van Houte Hans | CA | O | CFO | S | -75 | 21.45 | 0 | -3 | -6 | 51 | D | | | | | | | | | | | | | | |
8/1/24 19:06 | 8/1/24 | NRIX | Health | Drug | Pharmaceutical Preparations | Ring Christine | CA | O | GC | S.d | -123 | 21.43 | 0 | -6 | -19 | 25 | D | | | | | | | | | | | | | | |
8/1/24 19:06 | 8/1/24 | NRIX | Health | Drug | Pharmaceutical Preparations | Ring Christine | CA | O | GC | M.d | 11 | 1.86 | 0 | 6 | 31 | 25 | D | | | | | | | | | | | | | | |
7/30/24 19:06 | 7/30/24 | NRIX | Health | Drug | Pharmaceutical Preparations | Hansen Gwenn | CA | O | Chief Sc | S.d | -70 | 20.67 | 0 | -3 | -7 | 45 | D | | | | | | | | | | | | | | |
7/30/24 19:06 | 7/30/24 | NRIX | Health | Drug | Pharmaceutical Preparations | Hansen Gwenn | CA | O | Chief Sc | M.d | 0 | 0.00 | 0 | 9 | 25 | 45 | D | | | | | | | | | | | | | | |
7/30/24 19:06 | 7/30/24 | NRIX | Health | Drug | Pharmaceutical Preparations | Ring Christine | CA | O | GC | M.d | 0 | 0.00 | 0 | 8 | 45 | 25 | D | | | | | | | | | | | | | | |
7/30/24 19:06 | 7/30/24 | NRIX | Health | Drug | Pharmaceutical Preparations | Ring Christine | CA | O | GC | S.d | -60 | 20.67 | 0 | -3 | -11 | 25 | D | | | | | | | | | | | | | | |
7/30/24 19:06 | 7/30/24 | NRIX | Health | Drug | Pharmaceutical Preparations | Van Houte Hans | CA | O | CFO | S.d | -51 | 20.67 | 0 | -2 | -4 | 54 | D | | | | | | | | | | | | | | |
7/30/24 19:06 | 7/30/24 | NRIX | Health | Drug | Pharmaceutical Preparations | Van Houte Hans | CA | O | CFO | M.d | 0 | 0.00 | 0 | 9 | 19 | 54 | D | | | | | | | | | | | | | | |
7/1/24 18:35 | 7/1/24 | NRIX | Health | Drug | Pharmaceutical Preparations | Ring Christine | CA | O | GC | S.d | -120 | 20.81 | 0 | -6 | -23 | 20 | D | | | | | | | | | | | | | | |
7/1/24 18:35 | 7/1/24 | NRIX | Health | Drug | Pharmaceutical Preparations | Ring Christine | CA | O | GC | M.d | 11 | 1.86 | 0 | 6 | 41 | 20 | D | | | | | | | | | | | | | | |
6/20/24 16:58 | 6/20/24 | NRIX | Health | Drug | Pharmaceutical Preparations | Van Houte Hans | CA | O | CFO | S | -400 | 20.01 | 0 | -20 | -29 | 48 | D | | | | | | | | | | | | | | |
6/13/24 18:39 | 6/13/24 | NRIX | Health | Drug | Pharmaceutical Preparations | Ring Christine | CA | O | GC | S.d | -32 | 17.02 | 0 | -2 | -9 | 20 | D | | | | | | | | | | | | | | |
6/13/24 18:39 | 6/13/24 | NRIX | Health | Drug | Pharmaceutical Preparations | Ring Christine | CA | O | GC | M.d | 3 | 1.86 | 0 | 2 | 10 | 20 | D | | | | | | | | | | | | | | |
6/12/24 19:30 | 6/12/24 | NRIX | Health | Drug | Pharmaceutical Preparations | Ring Christine | CA | O | GC | S.d | -32 | 17.01 | 0 | -2 | -9 | 20 | D | | | | | | | | | | | | | | |
6/12/24 19:30 | 6/12/24 | NRIX | Health | Drug | Pharmaceutical Preparations | Ring Christine | CA | O | GC | M.d | 4 | 1.86 | 0 | 2 | 11 | 20 | D | | | | | | | | | | | | | | |
6/5/24 18:01 | 6/5/24 | NRIX | Health | Drug | Pharmaceutical Preparations | Ring Christine | CA | O | GC | S.d | -7 | 17.00 | 0 | 0 | -2 | 20 | D | | | | | | | | | | | | | | |
6/5/24 18:01 | 6/5/24 | NRIX | Health | Drug | Pharmaceutical Preparations | Ring Christine | CA | O | GC | M.d | 1 | 1.86 | 0 | 0 | 2 | 20 | D | | | | | | | | | | | | | | |
6/3/24 18:36 | 6/3/24 | NRIX | Health | Drug | Pharmaceutical Preparations | Ring Christine | CA | O | GC | S.d | -27 | 17.01 | 0 | -2 | -7 | 20 | D | | | | | | | | | | | | | | |
6/3/24 18:36 | 6/3/24 | NRIX | Health | Drug | Pharmaceutical Preparations | Ring Christine | CA | O | GC | M.d | 3 | 1.86 | 0 | 2 | 9 | 20 | D | | | | | | | | | | | | | | |
5/2/24 18:01 | 5/2/24 | NRIX | Health | Drug | Pharmaceutical Preparations | Van Houte Hans | CA | O | CFO | S | -45 | 12.83 | 0 | -3 | -5 | 68 | D | | | | | | | | | | | | | | |
4/30/24 18:33 | 4/30/24 | NRIX | Health | Drug | Pharmaceutical Preparations | Van Houte Hans | CA | O | CFO | S.d | -17 | 12.04 | 0 | -1 | -2 | 72 | D | | | | | | | | | | | | | | |
4/30/24 18:33 | 4/30/24 | NRIX | Health | Drug | Pharmaceutical Preparations | Van Houte Hans | CA | O | CFO | M.d | 0 | 0.00 | 0 | 5 | 7 | 72 | D | | | | | | | | | | | | | | |
4/30/24 18:33 | 4/30/24 | NRIX | Health | Drug | Pharmaceutical Preparations | Hansen Gwenn | CA | O | Chief Sc | S.d | -24 | 12.04 | 0 | -2 | -5 | 40 | D | | | | | | | | | | | | | | |
4/30/24 18:33 | 4/30/24 | NRIX | Health | Drug | Pharmaceutical Preparations | Hansen Gwenn | CA | O | Chief Sc | M.d | 0 | 0.00 | 0 | 5 | 15 | 40 | D | | | | | | | | | | | | | | |
4/30/24 18:33 | 4/30/24 | NRIX | Health | Drug | Pharmaceutical Preparations | Ring Christine | CA | O | GC | S.d | -18 | 12.04 | 0 | -2 | -7 | 20 | D | | | | | | | | | | | | | | |
4/30/24 18:33 | 4/30/24 | NRIX | Health | Drug | Pharmaceutical Preparations | Ring Christine | CA | O | GC | M.d | 0 | 0.00 | 0 | 4 | 25 | 20 | D | | | | | | | | | | | | | | |
2/16/24 19:20 | 2/16/24 | NRIX | Health | Drug | Pharmaceutical Preparations | Van Houte Hans | CA | O | CFO | S | -68 | 10.02 | 0 | -7 | -9 | 68 | D | | | | | | | | | | | | | | |
1/30/24 18:53 | 1/30/24 | NRIX | Health | Drug | Pharmaceutical Preparations | Van Houte Hans | CA | O | CFO | S.d | -13 | 7.99 | 0 | -2 | -2 | 75 | D | | | | | | | | | | | | | | |
1/30/24 18:53 | 1/30/24 | NRIX | Health | Drug | Pharmaceutical Preparations | Van Houte Hans | CA | O | CFO | M.d | 0 | 0.00 | 0 | 5 | 7 | 75 | D | | | | | | | | | | | | | | |
1/30/24 18:52 | 1/30/24 | NRIX | Health | Drug | Pharmaceutical Preparations | Hansen Gwenn | CA | O | Chief Sc | M.d | 0 | 0.00 | 0 | 5 | 17 | 36 | D | | | | | | | | | | | | | | |
1/30/24 18:52 | 1/30/24 | NRIX | Health | Drug | Pharmaceutical Preparations | Hansen Gwenn | CA | O | Chief Sc | S.d | -19 | 7.99 | 0 | -2 | -6 | 36 | D | | | | | | | | | | | | | | |
1/30/24 18:52 | 1/30/24 | NRIX | Health | Drug | Pharmaceutical Preparations | Ring Christine | CA | O | GC | S.d | -14 | 7.99 | 0 | -2 | -9 | 17 | D | | | | | | | | | | | | | | |
1/30/24 18:52 | 1/30/24 | NRIX | Health | Drug | Pharmaceutical Preparations | Ring Christine | CA | O | GC | M.d | 0 | 0.00 | 0 | 4 | 29 | 17 | D | | | | | | | | | | | | | | |
12/21/23 17:19 | 12/20/23 | NRIX | Health | Drug | Pharmaceutical Preparations | Van Houte Hans | CA | O | CFO | S | -35 | 10.00 | 0 | -4 | -5 | 72 | D | | | | | | | | | | | | | | |
12/20/23 16:55 | 12/19/23 | NRIX | Health | Drug | Pharmaceutical Preparations | Van Houte Hans | CA | O | CFO | S | -109 | 10.00 | 0 | -11 | -13 | 75 | D | | | | | | | | | | | | | | |
11/1/23 16:41 | 10/31/23 | NRIX | Health | Drug | Pharmaceutical Preparations | Van Houte Hans | CA | O | CFO | S.d | -6 | 5.20 | 0 | -1 | -1 | 86 | D | | | | | | | | | | | | | | |
11/1/23 16:41 | 10/30/23 | NRIX | Health | Drug | Pharmaceutical Preparations | Van Houte Hans | CA | O | CFO | M.d | 0 | 0.00 | 0 | 5 | 6 | 86 | D | | | | | | | | | | | | | | |
11/1/23 16:40 | 10/31/23 | NRIX | Health | Drug | Pharmaceutical Preparations | Ring Christine | CA | O | GC | S.d | -6 | 5.20 | 0 | -1 | -7 | 15 | D | | | | | | | | | | | | | | |
11/1/23 16:40 | 10/30/23 | NRIX | Health | Drug | Pharmaceutical Preparations | Ring Christine | CA | O | GC | M.d | 0 | 0.00 | 0 | 4 | 35 | 15 | D | | | | | | | | | | | | | | |
11/1/23 16:40 | 10/31/23 | NRIX | Health | Drug | Pharmaceutical Preparations | Hansen Gwenn | CA | O | Chief Sc | S.d | -8 | 5.20 | 0 | -2 | -5 | 34 | D | | | | | | | | | | | | | | |
11/1/23 16:40 | 10/30/23 | NRIX | Health | Drug | Pharmaceutical Preparations | Hansen Gwenn | CA | O | Chief Sc | M.d | 0 | 0.00 | 0 | 5 | 18 | 34 | D | | | | | | | | | | | | | | |
8/1/23 16:28 | 7/30/23 | NRIX | Health | Drug | Pharmaceutical Preparations | Van Houte Hans | CA | O | CFO | M.d | 0 | 0.00 | 0 | 5 | 6 | 83 | D | | | | | | | | | | | | | | |
8/1/23 16:28 | 7/31/23 | NRIX | Health | Drug | Pharmaceutical Preparations | Van Houte Hans | CA | O | CFO | S.d | -12 | 9.65 | 0 | -1 | -1 | 83 | D | | | | | | | | | | | | | | |
8/1/23 16:27 | 7/31/23 | NRIX | Health | Drug | Pharmaceutical Preparations | Ring Christine | CA | O | GC | S.d | -14 | 9.65 | 0 | -1 | -10 | 13 | D | | | | | | | | | | | | | | |
8/1/23 16:27 | 7/30/23 | NRIX | Health | Drug | Pharmaceutical Preparations | Ring Christine | CA | O | GC | M.d | 0 | 0.00 | 0 | 4 | 46 | 13 | D | | | | | | | | | | | | | | |
8/1/23 16:26 | 7/31/23 | NRIX | Health | Drug | Pharmaceutical Preparations | Hansen Gwenn | CA | O | Chief Sc | S.d | -18 | 9.65 | 0 | -2 | -6 | 30 | D | | | | | | | | | | | | | | |
8/1/23 16:26 | 7/30/23 | NRIX | Health | Drug | Pharmaceutical Preparations | Hansen Gwenn | CA | O | Chief Sc | M.d | 0 | 0.00 | 0 | 5 | 21 | 30 | D | | | | | | | | | | | | | | |
5/2/23 16:33 | 5/1/23 | NRIX | Health | Drug | Pharmaceutical Preparations | Wolff Stefani | CA | O | EVP,COO | S.d | -3 | 9.88 | 0 | 0 | -5 | 6 | D | | | | | | | | | | | | | | |
5/2/23 16:33 | 4/30/23 | NRIX | Health | Drug | Pharmaceutical Preparations | Wolff Stefani | CA | O | EVP,COO | M.d | 0 | 0.00 | 0 | 1 | 19 | 6 | D | | | | | | | | | | | | | | |
5/2/23 16:33 | 5/1/23 | NRIX | Health | Drug | Pharmaceutical Preparations | Van Houte Hans | CA | O | CFO | S.d | -7 | 9.88 | 0 | -1 | -1 | 79 | D | | | | | | | | | | | | | | |
5/2/23 16:33 | 4/30/23 | NRIX | Health | Drug | Pharmaceutical Preparations | Van Houte Hans | CA | O | CFO | M.d | 0 | 0.00 | 0 | 3 | 4 | 79 | D | | | | | | | | | | | | | | |
5/2/23 16:32 | 5/1/23 | NRIX | Health | Drug | Pharmaceutical Preparations | Ring Christine | CA | O | GC | S.d | -7 | 9.88 | 0 | -1 | -6 | 10 | D | | | | | | | | | | | | | | |
5/2/23 16:32 | 4/30/23 | NRIX | Health | Drug | Pharmaceutical Preparations | Ring Christine | CA | O | GC | M.d | 0 | 0.00 | 0 | 2 | 24 | 10 | D | | | | | | | | | | | | | | |
5/2/23 16:31 | 5/1/23 | NRIX | Health | Drug | Pharmaceutical Preparations | Hansen Gwenn | CA | O | Chief Sc | S.d | -11 | 9.88 | 0 | -1 | -4 | 27 | D | | | | | | | | | | | | | | |
5/2/23 16:31 | 4/30/23 | NRIX | Health | Drug | Pharmaceutical Preparations | Hansen Gwenn | CA | O | Chief Sc | M.d | 0 | 0.00 | 0 | 3 | 14 | 27 | D | | | | | | | | | | | | | | |
2/1/23 16:18 | 1/30/23 | NRIX | Health | Drug | Pharmaceutical Preparations | Wolff Stefani | CA | O | EVP,COO | S.d | -5 | 11.78 | 0 | 0 | -10 | 4 | D | | | | | | | | | | | | | | |
2/1/23 16:18 | 1/30/23 | NRIX | Health | Drug | Pharmaceutical Preparations | Wolff Stefani | CA | O | EVP,COO | M.d | 0 | 0.00 | 0 | 1 | 32 | 4 | D | | | | | | | | | | | | | | |
2/1/23 16:17 | 1/30/23 | NRIX | Health | Drug | Pharmaceutical Preparations | Van Houte Hans | CA | O | CFO | S.d | -11 | 11.78 | 0 | -1 | -1 | 77 | D | | | | | | | | | | | | | | |
2/1/23 16:17 | 1/30/23 | NRIX | Health | Drug | Pharmaceutical Preparations | Van Houte Hans | CA | O | CFO | M.d | 0 | 0.00 | 0 | 3 | 4 | 77 | D | | | | | | | | | | | | | | |
2/1/23 16:16 | 1/30/23 | NRIX | Health | Drug | Pharmaceutical Preparations | Ring Christine | CA | O | GC | S.d | -10 | 11.78 | 0 | -1 | -10 | 7 | D | | | | | | | | | | | | | | |
2/1/23 16:16 | 1/30/23 | NRIX | Health | Drug | Pharmaceutical Preparations | Ring Christine | CA | O | GC | M.d | 0 | 0.00 | 0 | 2 | 36 | 7 | D | | | | | | | | | | | | | | |
2/1/23 16:15 | 1/30/23 | NRIX | Health | Drug | Pharmaceutical Preparations | Hansen Gwenn | CA | O | Chief Sc | S.d | -17 | 11.78 | 0 | -1 | -6 | 23 | D | | | | | | | | | | | | | | |
2/1/23 16:15 | 1/30/23 | NRIX | Health | Drug | Pharmaceutical Preparations | Hansen Gwenn | CA | O | Chief Sc | M.d | 0 | 0.00 | 0 | 3 | 16 | 23 | D | | | | | | | | | | | | | | |
11/1/22 19:35 | 10/31/22 | NRIX | Health | Drug | Pharmaceutical Preparations | Van Houte Hans | CA | O | CFO | S.d | -10 | 12.88 | 0 | -1 | -1 | 75 | D | | | | | | | | | | | | | | |
11/1/22 19:35 | 10/30/22 | NRIX | Health | Drug | Pharmaceutical Preparations | Van Houte Hans | CA | O | CFO | M.d | 0 | 0.00 | 0 | 3 | 4 | 75 | D | | | | | | | | | | | | | | |
11/1/22 19:34 | 10/30/22 | NRIX | Health | Drug | Pharmaceutical Preparations | Ring Christine | CA | O | GC | M.d | 0 | 0.00 | 0 | 2 | 45 | 6 | D | | | | | | | | | | | | | | |
11/1/22 19:34 | 10/31/22 | NRIX | Health | Drug | Pharmaceutical Preparations | Ring Christine | CA | O | GC | S.d | -9 | 12.88 | 0 | -1 | -10 | 6 | D | | | | | | | | | | | | | | |
11/1/22 19:33 | 10/31/22 | NRIX | Health | Drug | Pharmaceutical Preparations | Hansen Gwenn | CA | O | Chief Sc | S.d | -15 | 12.88 | 0 | -1 | -5 | 21 | D | | | | | | | | | | | | | | |
11/1/22 19:33 | 10/30/22 | NRIX | Health | Drug | Pharmaceutical Preparations | Hansen Gwenn | CA | O | Chief Sc | M.d | 0 | 0.00 | 0 | 3 | 18 | 21 | D | | | | | | | | | | | | | | |
11/1/22 19:32 | 10/31/22 | NRIX | Health | Drug | Pharmaceutical Preparations | Wolff Stefani | CA | O | EVP,COO | S.d | -5 | 12.88 | 0 | 0 | -9 | 3 | D | | | | | | | | | | | | | | |
11/1/22 19:32 | 10/30/22 | NRIX | Health | Drug | Pharmaceutical Preparations | Wolff Stefani | CA | O | EVP,COO | M.d | 0 | 0.00 | 0 | 1 | 39 | 3 | D | | | | | | | | | | | | | | |
8/2/22 17:50 | 8/1/22 | NRIX | Health | Drug | Pharmaceutical Preparations | Ring Christine | CA | O | GC | S.d | -11 | 15.67 | 0 | -1 | -13 | 5 | D | | | | | | | | | | | | | | |
8/2/22 17:50 | 7/30/22 | NRIX | Health | Drug | Pharmaceutical Preparations | Ring Christine | CA | O | GC | M.d | 0 | 0.00 | 0 | 2 | 71 | 5 | D | | | | | | | | | | | | | | |
8/2/22 17:48 | 8/1/22 | NRIX | Health | Drug | Pharmaceutical Preparations | Wolff Stefani | CA | O | EVP,COO | S.d | -6 | 15.67 | 0 | 0 | -22 | 1 | D | | | | | | | | | | | | | | |
8/2/22 17:48 | 7/30/22 | NRIX | Health | Drug | Pharmaceutical Preparations | Wolff Stefani | CA | O | EVP,COO | M.d | 0 | 0.00 | 0 | 1 | 349 | 1 | D | | | | | | | | | | | | | | |
8/2/22 17:46 | 8/1/22 | NRIX | Health | Drug | Pharmaceutical Preparations | Van Houte Hans | CA | O | CFO | S.d | -12 | 15.67 | 0 | -1 | -1 | 73 | D | | | | | | | | | | | | | | |
8/2/22 17:46 | 7/30/22 | NRIX | Health | Drug | Pharmaceutical Preparations | Van Houte Hans | CA | O | CFO | M.d | 0 | 0.00 | 0 | 3 | 4 | 73 | D | | | | | | | | | | | | | | |
8/2/22 17:45 | 8/1/22 | NRIX | Health | Drug | Pharmaceutical Preparations | Hansen Gwenn | CA | O | Chief Sc | S.d | -19 | 15.67 | 0 | -1 | -6 | 19 | D | | | | | | | | | | | | | | |
8/2/22 17:45 | 7/30/22 | NRIX | Health | Drug | Pharmaceutical Preparations | Hansen Gwenn | CA | O | Chief Sc | M.d | 0 | 0.00 | 0 | 3 | 20 | 19 | D | | | | | | | | | | | | | | |
6/1/22 16:57 | 5/31/22 | NRIX | Health | Drug | Pharmaceutical Preparations | Van Houte Hans | CA | O | CFO | M.d | 57 | 0.8400 | 0 | 68 | 999% | 71 | D | | | | | | | | | | | | | | |
5/3/22 19:05 | 5/2/22 | NRIX | Health | Drug | Pharmaceutical Preparations | Hansen Gwenn | CA | O | Chief Sc | S.d | -13 | 11.75 | 0 | -1 | -6 | 17 | D | | | | | | | | | | | | | | |
5/3/22 19:05 | 4/30/22 | NRIX | Health | Drug | Pharmaceutical Preparations | Hansen Gwenn | CA | O | Chief Sc | M.d | 0 | 0.00 | 0 | 3 | 23 | 17 | D | | | | | | | | | | | | | | |
5/3/22 19:04 | 5/2/22 | NRIX | Health | Drug | Pharmaceutical Preparations | Wolff Stefani | CA | O | EVP,COO | S.d | -4 | 11.75 | 0 | 0 | -34 | 1 | D | | | | | | | | | | | | | | |
5/3/22 19:04 | 4/30/22 | NRIX | Health | Drug | Pharmaceutical Preparations | Wolff Stefani | CA | O | EVP,COO | M.d | 0 | 0.00 | 0 | 1 | | 1 | D | | | | | | | | | | | | | | |
5/3/22 19:03 | 5/2/22 | NRIX | Health | Drug | Pharmaceutical Preparations | Van Houte Hans | CA | O | CFO | S.d | -8 | 11.75 | 0 | -1 | -24 | 2 | D | | | | | | | | | | | | | | |
5/3/22 19:03 | 4/30/22 | NRIX | Health | Drug | Pharmaceutical Preparations | Van Houte Hans | CA | O | CFO | M.d | 0 | 0.00 | 0 | 3 | | 2 | D | | | | | | | | | | | | | | |
5/3/22 19:03 | 5/2/22 | NRIX | Health | Drug | Pharmaceutical Preparations | Ring Christine | CA | O | GC | S.d | -8 | 11.75 | 0 | -1 | -16 | 3 | D | | | | | | | | | | | | | | |
5/3/22 19:03 | 4/30/22 | NRIX | Health | Drug | Pharmaceutical Preparations | Ring Christine | CA | O | GC | M.d | 0 | 0.00 | 0 | 2 | 130 | 3 | D | | | | | | | | | | | | | | |
1/11/22 16:10 | 1/10/22 | NRIX | Health | Drug | Pharmaceutical Preparations | Ring Christine | CA | O | GC | S.d | -33 | 27.14 | 0 | -1 | -48 | 1 | D | | | | | | | | | | | | | | |
1/11/22 16:10 | 1/10/22 | NRIX | Health | Drug | Pharmaceutical Preparations | Ring Christine | CA | O | GC | M.d | 2 | 1.86 | 0 | 1 | 999% | 1 | D | | | | | | | | | | | | | | |
1/4/22 16:19 | 1/3/22 | NRIX | Health | Drug | Pharmaceutical Preparations | Hansen Gwenn | CA | O | Chief Sc | S.d | -53 | 28.96 | 0 | -2 | -11 | 14 | D | | | | | | | | | | | | | | |
1/4/22 16:19 | 1/3/22 | NRIX | Health | Drug | Pharmaceutical Preparations | Hansen Gwenn | CA | O | Chief Sc | M.d | 17 | 9.06 | 0 | 2 | 15 | 14 | D | | | | | | | | | | | | | | |